KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  224.22
+3.13 (1.42%)
AAPL  263.46
+3.88 (1.49%)
AMD  251.98
+16.99 (7.23%)
BAC  52.48
+0.72 (1.38%)
GOOG  260.95
+7.22 (2.85%)
META  737.38
+3.38 (0.46%)
MSFT  524.78
+4.22 (0.81%)
NVDA  186.60
+4.44 (2.44%)
ORCL  284.01
+3.94 (1.41%)
TSLA  431.75
-17.24 (-3.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.